[Synthetic antimycotica (author's transl)].
In addition to the antimycotic antibiotics described in a previous paper (Tijdschr. Diergeneesk., 101, 900-904, (1976)), the drugs used in the treatment of dermatomycosis include a fairly large number of synthtic compounds showing a wide variety of chemical structures. These are partly old and occasionally even obsolete agents (often in use as early as prior to 1945); a number of these drugs are of more recent date. They will be discussed in the present paper. So far as is known, the physicochemical and pharmacotoxicological properties, antifungal range, mechanisms of action and preparations will be reviewed.
D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects; D003881:Dermatomycoses / Q000188:drug therapy*; D004003:Dichlorophen / Q000494:pharmacology; D004821:Epidermophyton / Q000187:drug effects; D005227:Fatty Acids / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D008864:Microsporum / Q000187:drug effects; D015125:Oxyquinoline / Q000494:pharmacology; D013827:Thiabendazole / Q000494:pharmacology; D013829:Thiadiazines / Q000494:pharmacology; D014047:Tolnaftate / Q000494:pharmacology; D014249:Trichophyton / Q000187:drug effects
D000935:Antifungal Agents; D005227:Fatty Acids; D007093:Imidazoles; D013829:Thiadiazines; D014047:Tolnaftate; D015125:Oxyquinoline; D013827:Thiabendazole; D004003:Dichlorophen
Synthetische antimycotica